Xie HT, An DH, Wu DB. Intracranial hypertension as the primary symptom of malignant melanoma: A case report. World J Clin Cases 2024; 12(21): 4836-4841 [PMID: 39070805 DOI: 10.12998/wjcc.v12.i21.4836]
Corresponding Author of This Article
Duo-Bin Wu, MD, PhD, Professor, Department of Neurology, Zhujiang Hospital of Southern Medical University, No. 253 Industry Road, Haizhu District, Guangzhou 510282, Guangdong Province, China. 936861404@qq.com
Research Domain of This Article
Clinical Neurology
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Xie HT, An DH, Wu DB. Intracranial hypertension as the primary symptom of malignant melanoma: A case report. World J Clin Cases 2024; 12(21): 4836-4841 [PMID: 39070805 DOI: 10.12998/wjcc.v12.i21.4836]
World J Clin Cases. Jul 26, 2024; 12(21): 4836-4841 Published online Jul 26, 2024. doi: 10.12998/wjcc.v12.i21.4836
Intracranial hypertension as the primary symptom of malignant melanoma: A case report
Hai-Ting Xie, Ding-Hao An, Duo-Bin Wu
Hai-Ting Xie, Department of Neurology, Southern Medical University, Guangzhou 510282, Guangdong Province, China
Ding-Hao An, Department of Neurology, Nanjing Drum Tower Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing 210008, Jiangsu Province, China
Duo-Bin Wu, Department of Neurology, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, Guangdong Province, China
Co-first authors: Hai-Ting Xie and Ding-Hao An.
Author contributions: Xie HT, An DH, and Wu DB designed the study; Xie HT and An DH performed the research; An DH obtained the consent form of the patient; Xie HT and An DH wrote the manuscript; Wu DB reviewed and revised the manuscript; All authors have read and approved the final manuscript.
Informed consent statement: An informed consent form was signed by the parents of the case patient to approve the use of patient information or material for scientific purposes.
Conflict-of-interest statement: All authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Duo-Bin Wu, MD, PhD, Professor, Department of Neurology, Zhujiang Hospital of Southern Medical University, No. 253 Industry Road, Haizhu District, Guangzhou 510282, Guangdong Province, China. 936861404@qq.com
Received: April 19, 2024 Revised: May 19, 2024 Accepted: June 7, 2024 Published online: July 26, 2024 Processing time: 72 Days and 23.4 Hours
Abstract
BACKGROUND
The etiological diagnosis of intracranial hypertension is quite complicated but important in clinical practice. Some common causes are craniocerebral injury, intracranial space-occupying lesion, subarachnoid hemorrhage, and hydrocephalus. When a patient presents with intracranial hypertension, the common causes are to be considered first so that other causes would be dismissed. With the morbidity lower than 9%, neuromelanin is very rare. Common symptoms include nerve damage symptoms, epilepsy, psychiatric symptoms, and cognitive disorders.
CASE SUMMARY
We present a patient with melanoma which manifested with isolated intracranial hypertension without any other neurological signs. A 22-year-old male had repeated nausea and vomiting for 2 mo with Babinski sign (+) on both sides, nuchal rigidity, and subarachnoid hemorrhage. He had been diagnosed with melanoma and was given surgery and whole-brain radiation. Ultimately, the patient died 2 mo later.
CONCLUSION
Malignant melanoma should be taken into consideration in the differential diagnosis of intracranial hypertension.
Core Tip: This manuscript is a case report. We report on a patient with malignant melanoma who primarily presented with intracranial hypertension. With no other symptoms except intracranial hypertension, the process of etiological diagnosis was hard and thought-provoking. Moreover, there are few melanoma cases that manifested with intracranial hypertension alone.
